Private Equity Looks To Small, Mid-Size Drug Makers Risking Growth (India)
This article was originally published in PharmAsia News
Executive Summary
Private-equity firms appear increasingly interested in supporting outsourcing ventures among small and mid-size pharmaceutical companies. According to Dr. Sandeep Singhai of Sequoia Capital, that area of drug making is growing faster than growth in the established sectors, so his company is investing in those smaller firms that seek to become major players, despite the added risk of doing so. Another investor notes those types of drug makers already are into contract manufacturing and outsourcing, areas that hold huge potential. (Click here for more